CorMedix Inc. CRMD
$8.23
+0.73%
at last close
Market Cap$645.66 million
P/E Ratio4.03
Div Yield—
Volume836.0K
52-Week Range
$6.13$17.43
Key Stats
- Today's Range
- $8.09 – $8.27
- 50-Day Range
- $6.31 – $8.94
- 52-Week Range
- $6.13 – $17.43
- Volume
- 836K shs
- Average Volume
- 1.27 million shs
- Market Cap
- $645.66 million
- P/E Ratio
- 4.03
- Dividend Yield
- —
Valuation
- P/E Ratio
- 4.03
- Price / Book
- 1.48
- Price / Sales
- 1.61
Short Interest
- Short Interest
- 5.10%
- Days to Cover
- 2.46
Financials (TTM)
- Revenue
- $400.05 million
- Net Income
- $181.01 million
- Net Margin
- 45.25%
- Return on Equity
- 41.42%
- Debt-to-Equity
- —
About CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.